Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

Amyloid

Volumn 17, Issue 3-4, 2010, Pages 101-104

  Sipe, Jean D ^a   Benson, Merrill D ^b   Buxbaum, Joel N ^c   Ikeda, Shu Ichi ^d   Merlini, Giampaolo ^e   Saraiva, Maria J M ^f   Westermark, Per ^g  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY OF PORTO   (Portugal)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

amyloid fibril; amyloid protein; Amyloidosis; inclusion body

Indexed keywords

AMYLOID PROTEIN;

AMYLOIDOSIS; HUMAN; MEDICAL SOCIETY; NOMENCLATURE; NONHUMAN; POLARIZATION MICROSCOPY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SHORT SURVEY;

AMYLOID; AMYLOIDOSIS; ANIMALS; HUMANS; SOCIETIES, SCIENTIFIC;

EID: 78649315112     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2010.526812     Document Type: Short Survey

References (13)

1. Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee. Bull World Health Organ 1993;71:105-112.
2. Cohen AS, Franklin EC, Glenner GG, Natvig JB, Osserman EF, Wegelius O. Nomenclature. In: Wegelius O, Pasternack A, editors. Amyloidosis. London: Academic Press; 1976. pp ix.
3. Benditt EP, Cohen AS, Costa PP, Franklin EC, Glenner GG, Husby G, Mandema E, Natvig JB, Osserman EF, Sohar E, Wegelius O, Westermark P. Guidelines for nomenclature. In: Glenner GG, Costa PP, Freitas AF, editors. Amyloid and amyloidosis, Amsterdam: Excerpta Medica; 1980. pp XI-XII.
4. Husby G, Araki S, Benditt EP, Benson MD, Cohen AS, Frangione B, Glenner GG, Natvig JB, Westermark P. The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. In: Natvig JB, Förre O Husby G, Husebekk A, Skogen B, Sletten K, Westermark P, editors. Amyloid and amyloidosis 1990. Dordrecht: Kluwer; 1991. pp 7-11.
5. Westermark P. Classification of amyloid fibril proteins and their precursors: an ongoing discussion. Amyloid 1997;4:216-218.
6. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD. Amyloid fibril protein nomenclature - 2002. Amyloid 2002;9:197-200.
7. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda SI, Masters CL, Merlini G, Saraiva MJ, Sipe JD. Amyloid: toward terminology classification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2005;12:1-4.
8. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda SI, Masters CL, Merlini G, Saraiva MJ, Sipe JD. A primer of amyloid nomenclature. Amyloid 2007;14:179-183.
9. Sipe J. Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2. Amyloid 1999;6:67-70.
10. Maury CP. The emerging concept of functional amyloid. J Intern Med 2009;265:329-334.
11. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid-from bacteria to humans. Trends Biochem Sci 2007;32:217-224.
12. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KP, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale W, Riek R. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009;325:328-332.
13. Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B. Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int 2008;74:218-222.